Novel bovine viral diarrhea virus (BVDV) virus-like particle vaccine candidates presenting the E2 protein using the SpyTag/SpyCatcher system induce a robust neutralizing antibody response in mice
Archives of Virology · 2023
DOI: 10.1007/s00705-022-05653-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Virology, 2023. Verfasst von Miki Katsura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Environmental Microbiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. Hauptthemen laut MEDLINE: Vaccines, Virus-Like Particle, Viral Vaccines, Diarrhea Viruses, Bovine Viral, Diarrhea Virus 1, Bovine Viral. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Bovine viral diarrhea virus (BVDV) is a pathogen of commercial consequence in cattle. Although many modified live and killed vaccines are commercially available, their drawbacks precipitate the need for new effective vaccines. Virus-like particles (VLPs) are a safe and powerful technology used in several human and veterinary vaccines; however, it is difficult to produce large amounts of BVDV VLPs. In this study, we generated red-spotted grouper nervous necrosis virus (RGNNV) VLPs presenting the BVDV E2 protein (domain I to IIIb) of the Nose (BVDV-1) or KZ-91-CP (BVDV-2) strain by exploiting SpyTag/SpyCatcher technology. Mice immunized twice with 30 μg of RGNNV VLPs conjugated with 10 μg of E2 proteins of the Nose or KZ-91-CP strain with a 14-day interval elicited high (1:512,000 to 1:1,024,000) and moderate (1:25,600 to 1:102,400) IgG titers against E2 proteins of homologous and heterologous strains, respectively. In addition, this prime-boost regimen induced strong (1:800 to 1:3,200) and weak (~1:10) neutralization titers against homologous and heterologous BVDV strains, respectively. Our results indicate that conjugation of the E2 protein to RGNNV VLPs strongly enhances the antigenicity of the E2 protein and that RGNNV VLPs presenting the E2 protein are promising BVDV vaccine candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Environmental Microbiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
- Exotic Disease Research Group, National Institute of Animal Health, National Agriculture and Food Research Organization (NARO), 6-20-1 Josuihoncho, Kodaira, Tokyo, 187-0022, Japan.
- College of Agriculture, Ibaraki University, 3-21 Chuo, Ami, Ibaraki, 300-0332, Japan.
- Laboratory of Environmental Microbiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. ktakeuch@md.tsukuba.ac.jp.
Förderung
- JSPS KAKENHI
Zitieren
APA
Katsura, M., Fukushima, M., Kameyama, K. I., Kokuho, T., Nakahira, Y., & Takeuchi, K. (2023). Novel bovine viral diarrhea virus (BVDV) virus-like particle vaccine candidates presenting the E2 protein using the SpyTag/SpyCatcher system induce a robust neutralizing antibody response in mice. Archives of Virology. https://doi.org/10.1007/s00705-022-05653-x
Vancouver
Katsura M, Fukushima M, Kameyama KI, Kokuho T, Nakahira Y, Takeuchi K. Novel bovine viral diarrhea virus (BVDV) virus-like particle vaccine candidates presenting the E2 protein using the SpyTag/SpyCatcher system induce a robust neutralizing antibody response in mice. Archives of Virology. 2023. doi:10.1007/s00705-022-05653-x
BibTeX
@article{Katsura2023,
author = {Katsura, Miki and Fukushima, Masaki and Kameyama, Ken-Ichiro and Kokuho, Takehiko and Nakahira, Yoichi and Takeuchi, Kaoru},
title = {Novel bovine viral diarrhea virus (BVDV) virus-like particle vaccine candidates presenting the E2 protein using the SpyTag/SpyCatcher system induce a robust neutralizing antibody response in mice},
journal = {Archives of Virology},
year = {2023},
doi = {10.1007/s00705-022-05653-x}
}
EUVIMED